Thomas Först

13.7k citations
229 papers · 7.5k · 2 hit papers · h-index 46

Impact in

Papers in

    • Diabetes Treatment and Management 60
    • Diabetes Management and Research 50
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 16
    • Diabetes, Cardiovascular Risks, and Lipoproteins 11
    • Pancreatic function and diabetes 22

Thomas Först

216 papers receiving 7.2k citations

Thomas Först's Hit Papers

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial 2014 · 395 citations
3950+4+9Years since publication100200300400

Peers

Thomas Först
Comparison fields: 5 of 146
  • Endocrinology, Diabetes and Metabolism 3.8k
  • Surgery 1.4k
  • Endocrine and Autonomic Systems 204
  • Pharmacology 480
  • Physiology 654
Replace Ananda Basu with:
Ananda Basu United States
Robert Sherwin United States
Andreas Pfützner Germany
Vanita R. Aroda United States
Wayne Huey‐Herng Sheu Taiwan
Guntram Schernthaner Austria
Daniel Einhorn United States
W. Timothy Garvey United States
Bruno Vergès France
Avraham Karasik Israel
Thomas Först relative to Ananda Basu United States Ananda Basu's profile →
Citations per field
00.5×1.5×
Ananda Basu · 1×
Citations per year

Countries citing papers authored by Thomas Först

Since Specialization
Citations

This map shows the geographic impact of Thomas Först's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Först with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Först more than expected).

Fields of papers citing papers by Thomas Först

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Först. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Först. The network helps show where Thomas Först may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Först, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Först Line = papers co-authored together Thomas Först links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 229 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
Hit paper breakdown →
2012463
2
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
Hit paper breakdown →
2014395
3 2005234
4 2013224
5 2014222
6 2005220
7 2015217
8 2006175
9 2013163
10
Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
2003144
11 2007142
12 2016134
13 2004124
14 1997114
15 2010110
16 2015102
17 1998101
18 2003100
19 200087
20 199580

About Thomas Först

Thomas Först is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Epidemiology and Physiology, having authored 229 papers that have together received 7.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (60 papers), Diabetes Management and Research (50 papers), Pancreatic function and diabetes (22 papers), Diabetes and associated disorders (21 papers), Metabolism, Diabetes, and Cancer (18 papers), Adipokines, Inflammation, and Metabolic Diseases (16 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (16 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.8k citations), Surgery (1.4k citations), Endocrine and Autonomic Systems (204 citations), Pharmacology (480 citations) and Physiology (654 citations). Thomas Först has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Andreas Pfützner, T. Kunt, G Lübben, C Hohberg, M Hanefeld, Peter Herbert Kann, Matthias Langenfeld, Thomas R. Konrad, Christoph Kapitza and Matthias M. Weber. Their work appears in journals such as Journal of Diabetes Science and Technology, Diabetes Technology & Therapeutics, Diabetes Obesity and Metabolism, Experimental and Clinical Endocrinology & Diabetes and Hormone and Metabolic Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact